0001714899-23-000108.txt : 20230719 0001714899-23-000108.hdr.sgml : 20230719 20230719170914 ACCESSION NUMBER: 0001714899-23-000108 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230717 FILED AS OF DATE: 20230719 DATE AS OF CHANGE: 20230719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SATO VICKI L CENTRAL INDEX KEY: 0001197020 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38311 FILM NUMBER: 231097431 MAIL ADDRESS: STREET 1: 940 WINTER STREET STREET 2: PERKINELMER, INC. LEGAL DEPARTMENT CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Denali Therapeutics Inc. CENTRAL INDEX KEY: 0001714899 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 463872213 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 161 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 866-8548 MAIL ADDRESS: STREET 1: 161 OYSTER POINT BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 wk-form4_1689800946.xml FORM 4 X0508 4 2023-07-17 0 0001714899 Denali Therapeutics Inc. DNLI 0001197020 SATO VICKI L C/O DENALI THERAPEUTICS INC. 161 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 1 0 0 0 1 Common Stock 2023-07-17 4 S 0 1666 29.60 D 133037 D The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted March 27, 2023. The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $29.35 to $29.94 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price. Includes 4,216 RSUs. /s/ Alexander Schuth, by power of attorney 2023-07-19